
Rapid value assessment and price prediction
GPI horizon is a unique platform solution, based on our award-winning methodology, that quantifies an asset’s position in the market.
Using the latest technology and robust data sources, GPI horizon delivers rapid value assessment and price prediction to inform: portfolio strategy and prioritisation, investment decisions for early assets, strategic price and access planning for assets leading up to launch, price revisions throughout the product lifecycle. This makes GPI horizon perfect for not only price forecasting, but for quick and valuable insights throughout your asset's lifecycle.
See how GPI horizon works by viewing our research example, winner of the ISPOR research award.
GET A FREE ASSET EVALUATION WITH THE LAUNCH OF GPI HORIZON!
Schedule a free demo
Why use GPI horizon's value assessment & price prediction platform

Speed & Agility
Take a faster, data-driven approach to pricing and access research, using predictive payer analytics. Understand your asset’s position in the market from a clinical, price, and payer perspective.
Robustness
GPI horizon frameworks are validated by payers and country experts, incorporating a holistic view of payer value perception. The outputs are based on robust, objective data, adding to information gained from any payer interviews.
Transparency
No black box - clear methodology, providing transparency and confidence across the business. GPI horizon leverages both GPI pulse™ and other external data sources (e.g. HTA documents, clinical peer-reviewed publications, etc.)
Flexibility
GPI horizon is applicable throughout the asset timeline, and can be adapted to most therapy areas. It can also be combined with GPI consulting service to inform strategic direction and considerations, providing for a truly bespoke solution.
Schedule a free demo

GPI horizon provides a continuous, agile journey - underpinned by data
Traditional pricing and access activities are resource intensive and provide a snapshot in time. GPI horizon enables a faster and more agile way of working that is backed by GPI pulse™ data.
Wherever you are in the product lifecycle, and we’ll create the right solution for you:
BD&L / Early Pipeline
Pre-clinical – Early Phase 2
BD&L / Early Pipeline
• Rapid and more comprehensive asset evaluations to inform investment decisions
• Analogue selection supported by data from comprehensive GPI pulse™ database
• Test alternative scenarios and multiple assets quickly
• Transparent and payer-validated methodology
• Reduce internal burden and lengthy contracting
Late Phase
Phase 2-3
Late Phase
• Bespoke strategy and actionable recommendations from experienced P&MA consulting team
• Analogue selection supported by data from comprehensive GPI pulse™ database
• Faster project timelines leveraging analytical framework and readily available data
• Transparent and payer-validated methodology
• Rapid and continuous assessment of scenarios in response to evolving landscape
The challenges horizon overcomes
Need for faster insights
Need for instant, robust data for decision making
Increased pressure for P&MA teams to monitor landscape
Increased speed of drug launches
No analytical tools on the market to help
Leverage GPI horizon throughout the development lifecycle, and most therapy areas
How GPI horizon can be used
Self-serve platform subscription
Self-serve platform subscription
Evaluations completed by the user – instantly.
Serviced platform subscription
Serviced Platform Subscription
Evaluations completed on-demand by GPI consulting.
Time frame: 3-10 business days per evaluation
Bespoke pricing & market access strategy projects
Bespoke Pricing & Access Strategy Projects
Project delivered by GPI consulting.
Time frame: 8 weeks on average, subject to scope.
Get a complimentary asset evaluation as part of the GPI horizon platform launch
Engage with us
Register your interest
in GPI solutions
Sign up for
GPI updates